Cargando…
Comparison of the effect of Dapagliflozin and Pioglitazone on the risk of osteoporosis in postmenopausal women with Type-2 diabetes
OBJECTIVE: Type 2 Diabetes mellitus (T2DM) and osteoporosis, which increase with age, are two common diseases with different complications. The risk of fractures due to osteoporosis is 2 to 6 times higher in patients with diabetes mellitus (DM). Medications used in the treatment of DM in addition to...
Autor principal: | Son, Osman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480740/ https://www.ncbi.nlm.nih.gov/pubmed/37680820 http://dx.doi.org/10.12669/pjms.39.5.7580 |
Ejemplares similares
-
Risk Factors for Osteoporosis in Postmenopausal Women
por: Bijelic, Radojka, et al.
Publicado: (2017) -
Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA(1c), Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
por: Rosenstock, Julio, et al.
Publicado: (2012) -
Effects of Yogasanas on osteoporosis in postmenopausal women
por: Motorwala, Zainab S, et al.
Publicado: (2016) -
Risk management in the treatment of type 2 diabetes with pioglitazone
por: Derosa, Giuseppe, et al.
Publicado: (2009) -
Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)